China (Mainland)
Lurasidone hydrochloride CAS NO.367514-88-3 CAS NO.367514-88-3
- Min.Order: 10 Gram
- Payment Terms: T/T,Other
- Product Details
Keywords
- Lurasidone hydrochloride
- 367514-88-3
- High purity Lurasidone hydrochloride
Quick Details
- ProName: Lurasidone hydrochloride CAS NO.367514...
- CasNo: 367514-88-3
- Molecular Formula: C47H55ClF3N5O6S3
- Appearance: White powder
- Application: Used in medical research. Pharmaceutic...
- DeliveryTime: within 3 days after payment
- PackAge: Aluminum foil bag packaging
- Port: ShangHai,China
- ProductionCapacity: 5000 Kilogram/Month
- Purity: >99%
- Storage: Preserve in a well-closed container a...
- Transportation: by sea or air or express delivery or s...
- LimitNum: 10 Gram
Superiority
1, Quality:
Our company is a professional production of intermediates and chemicals for many years, our products have exported to Germany, Spain, UK, USA, Australia, Middle East, and so on other countries, and we have got very good feedback from our customers.so you can trust us.
And we are the manufactory, so you don’t need to doubt the quality.
2, Payment method: for example T/T, D/A, L/C, Westerm Union,other
3, Service: Best service and after-sales service to all clients.
1)We will ship the goods within 5days after get your payments.If you want to cancel or change order, please tell me within 24hours after you finish the payment...So we both can make the best of the bad bargain.
2)We will ship the goods that you order from us by HKEMS, DHL, UPS, TNT and EUB.We will decided to choose which courier depend on different countries.To find the best way to delivery the goods for you.
3)As usual you can get the goods with in 4-7days.If the goods were lost or not received for other reasons, please contact us immediately.
4, Delivery:
Sample Order : As usual you can get the goods within 4-7days. We can send it via HKems, HK Air Post, DHL or other methods.
We have a professional and stable logistics, and we can deliver the package smoothly around 3 to 5 days.
Bulk Order: Shipped via sea or air, it's according to your requirement, delivery time is 7-15days after payment.
If you have any other questions to consult me,please not hesitate to contact me any times.
Details
1. Lurasidone hydrochloride
2.White solid powder
3.assay no less than 99%
4.stock available
5.competitive price
| product name | Lurasidone Hydrochloride |
| chemical name | (3aR,4S,7R,7aS)-2-[(1R,2R)-2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-ylmethyl]cyclohexylmethyl]hexahydro-1H-4,7-methanoisoindole-1,3-dione hydrochloride |
| Molecular Formula | C28H36N4O2S.HCl |
| Molecular weight | 529.14 |
| CAS NO. | 367514-88-3 |
| Quality standard | Enterprise standard |
| Apperance | Light yellow powder, smelless, a little sweet. |
| Purity | 99%HPLC |
Function:
lurasidone characteristics of atypical antipsychotic drugs, the exact mechanisms in the treatment of schizophrenia like other atypical antipsychotics as not very clear, may be related to the dopamine D2 and serotonin (5-HT2A 5- 2A) on the antagonistic effect of receptor. For the treatment of schizophrenia, studies have reported lurasidone can improve cognitive function.
Adverse reaction: common adverse reactions are nausea, somnolence, sit not, Parkinson's disease and anxiety. Lurasidone no physical dependence. Lurasidone less cause weight gain, is not caused by glucose, lipid (Lei Zhi), change ECG and QT interval.
Contraindications: any known on ATUDA or the preparation of any of the components of hypersensitivity. At the same time, giving a strong CYP3A4 inhibitors such as [ketoconazole], ketoconazole and inducers such as rifampin, [rifampin].Cerebrovascular adverse reaction: antipsychotic use in atypical with dementia related psychosis in elderly patients treated had seen the incidence of cerebrovascular adverse events (such as increase, stroke, transient ischemic attack); neuroleptic malignant syndrome: immediate termination of treatment and close monitoring; tardive dyskinesia: such as clinical appropriate withdrawal; metabolic changes: atypical antipsychotics have accompanied by metabolic changes may increase cardiovascular / CEREBROVASCULAR risk. These metabolic changes including hyperglycemia, dyslipidemia, and weight gain.
Hyperglycemia and diabetes: monitoring in patients with hyperglycemia symptoms include polyuria, polydipsia, polyphagia, and weak. In patients with diabetes or at risk of diabetes in the regular monitoring of glucose.
Weight: weight gain recommendations once observed, clinical monitoring weight.